Genomma Lab Internacional Income Statement

Financials in millions MXN. Fiscal year is January - December.

Millions MXN. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	17,541	18,607	16,467	16,820	15,487
Revenue Growth (YoY)	-5.73%	12.99%	-2.10%	8.61%	11.66%
Cost of Revenue	6,519	6,676	6,384	6,656	5,924
Gross Profit	11,022	11,931	10,083	10,164	9,563
Selling, General & Admin	7,292	8,055	6,889	6,922	6,570
Other Operating Expenses	-29.64	-37.44	-12.65	-2.29	-63.44
Operating Expenses	7,262	8,018	6,876	6,920	6,507
Operating Income	3,760	3,913	3,207	3,244	3,056
Interest Expense	-1,048	-887.8	-829.9	-525.64	-444.39
Interest & Investment Income	-	106.11	156.93	118.05	65.43
Earnings From Equity Investments	-	-	-	-	-90.38
Currency Exchange Gain (Loss)	-	113.58	-543.51	-208.75	-25.92
Other Non Operating Income (Expenses)	-278.03	-363.29	-264.05	-394.78	-329.42
EBT Excluding Unusual Items	2,434	2,882	1,727	2,232	2,232
Asset Writedown	-	-	-8.07	-17.57	-5.52
Other Unusual Items	-	9.04	2.1	19.21	-4.26
Pretax Income	2,434	2,891	1,721	2,234	2,222
Income Tax Expense	826.24	799.98	635.67	867.61	914.01
Earnings From Continuing Operations	1,607	2,091	1,085	1,366	1,308
Net Income to Company	1,607	2,091	1,085	1,366	1,308
Net Income	1,607	2,091	1,085	1,366	1,308
Net Income to Common	1,607	2,091	1,085	1,366	1,308
Net Income Growth	-23.13%	92.74%	-20.60%	4.48%	-6.81%
Shares Outstanding (Basic)	974	978	957	993	1,008
Shares Outstanding (Diluted)	974	978	957	993	1,008
Shares Change (YoY)	-0.43%	2.20%	-3.61%	-1.43%	-0.41%
EPS (Basic)	1.65	2.14	1.13	1.38	1.30
EPS (Diluted)	1.65	2.14	1.13	1.38	1.30
EPS Growth	-22.80%	88.59%	-17.63%	5.99%	-6.43%
Free Cash Flow	1,507	2,763	2,009	1,652	838.14
Free Cash Flow Per Share	1.55	2.82	2.10	1.66	0.83
Dividend Per Share	-	0.800	0.784	0.382	0.382
Dividend Growth	-	2.00%	105.49%	-	-
Gross Margin	62.84%	64.12%	61.23%	60.43%	61.75%
Operating Margin	21.43%	21.03%	19.48%	19.28%	19.73%
Profit Margin	9.16%	11.24%	6.59%	8.12%	8.45%
Free Cash Flow Margin	8.59%	14.85%	12.20%	9.82%	5.41%
EBITDA	4,139	4,273	3,434	3,471	3,227
EBITDA Margin	23.59%	22.96%	20.86%	20.63%	20.83%
D&A For EBITDA	379.14	359.59	227.3	227.13	170.27
EBIT	3,760	3,913	3,207	3,244	3,056
EBIT Margin	21.43%	21.03%	19.48%	19.28%	19.73%
Effective Tax Rate	33.95%	27.67%	36.95%	38.84%	41.14%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.